News Focus
News Focus
icon url

Real McCoy

07/01/24 7:33 AM

#145410 RE: User-656209 #145409

There is no way anyone can say “all the patents were sold” when the last ever press release from the company said “On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment.”

Why would they be keeping any patents after the point where they had any employees to manage them?

Dude what is seriously going on here?
icon url

toncatmad

07/01/24 8:56 AM

#145416 RE: User-656209 #145409

You have that backwards. Simply read the legacy assignment showing BioAmber as the assignor and LCYB as the assignee of All the patents.
The monitor records, court records and the USTPO legacy assignment prove that all the assets and patents sold to LCYB free of incumbencies anyone who states otherwise is a liar.
Since you still haven’t learned how a liquidation works I’m sure you won’t believe the official records but your belief is not required to make it true as it is reality nonetheless